GO:1990682 CSF1-CSF1R complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990682 defines the CSF1-CSF1R complex, a heteromeric assembly of a CSF1 dimer bound to a dimerized CSF1R receptor.
• Formation of the complex requires ligand-induced receptor dimerization, a hallmark of class III receptor tyrosine kinase activation.
• The CSF1-CSF1R complex drives monocyte/macrophage survival, proliferation, and differentiation, and is a major therapeutic target in oncology.
• Dysregulated CSF1-CSF1R signaling is implicated in malignant pleural effusion, pancreatic cancer, chronic lymphocytic leukemia, and allotransplantation-associated vascular remodeling.
• CRISPR-based knockout, point-mutation, and knock-in models are essential to dissect the causal roles of CSF1, CSF1R, and interacting partners such as TREM2.
• EDITGENE provides end-to-end CRISPR services to generate and validate cell models for studying the CSF1-CSF1R complex and its downstream biology.
Description
The CSF1-CSF1R complex (GO:1990682) is a cellular component defined as a protein complex consisting of a macrophage colony-stimulating factor (CSF1, also called M-CSF) dimer bound to a dimerized receptor (CSF1R, also called FMS), where receptor dimerization requires the presence of the ligand. This complex represents the activated state of the CSF1 receptor tyrosine kinase and is the central signaling unit that controls the survival, proliferation, and differentiation of mononuclear phagocytes, including monocytes, macrophages, and microglia. Because of its pivotal role in myeloid cell biology, the CSF1-CSF1R complex has become a high-priority target for therapeutic intervention in cancer, inflammatory diseases, and transplantation. Researchers studying the CSF1-CSF1R complex seek to understand how ligand binding triggers receptor dimerization, how the complex assembles at the plasma membrane, and how its downstream signals are transduced and regulated. The complex is not merely a static entity; its formation is dynamic and tightly controlled, and its dysregulation contributes to a wide range of pathological conditions, from malignant pleural effusion to chronic lymphocytic leukemia. Recent studies have also highlighted the interplay between CSF1R and other immune receptors, such as TREM2, further expanding the complexity of the signaling network. In this article, we provide a comprehensive overview of the CSF1-CSF1R complex, covering its definition, structure, molecular mechanism, key genes, regulation, disease associations, and the experimental models and methods used to study it. We emphasize the importance of CRISPR-based approaches for functional validation and offer insights into how EDITGENE's services can accelerate research on this critical signaling complex.
CSF1-CSF1R complex At A Glance
| GO ID | GO:1990682 |
|---|---|
| GO term | CSF1-CSF1R complex |
| Ontology | cellular_component |
| Synonym | CSF1:C-FMS complex; macrophage colony-stimulating factor:receptor complex; M-CSF:C-FMS complex; M-CSF:CSF1R complex; M-CSF:FMS complex |
| Major function | Ligand-induced receptor dimerization and activation of CSF1R signaling, controlling monocyte/macrophage survival, proliferation, and differentiation |
| Complex composition | A CSF1 dimer bound to a CSF1R dimer |
| Assembly requirement | Receptor dimerization requires the presence of the ligand |
| Cellular location | Plasma membrane |
| Related diseases | Malignant pleural effusion, pancreatic cancer, chronic lymphocytic leukemia, allotransplantation-induced vascular remodeling |
What Is GO:1990682?
According to the Gene Ontology, GO:1990682 (CSF1-CSF1R complex) is a protein complex consisting of a macrophage colony-stimulating factor (CSF1, also called M-CSF) dimer bound to a dimerized receptor (CSF1R, also called FMS). Receptor dimerization requires the presence of the ligand. This definition captures the ligand-receptor assembly that initiates CSF1R signaling and is a key cellular component in myeloid cell biology.
Why Is CSF1-CSF1R complex Important in Cell Biology?
The CSF1-CSF1R complex is a central node in the regulation of the mononuclear phagocyte system and is critically involved in both normal physiology and disease. Its formation triggers autophosphorylation of CSF1R and activation of downstream signaling pathways that promote cell survival, proliferation, and differentiation. In cancer, tumor-associated macrophages (TAMs) rely on CSF1-CSF1R signaling to support tumor growth, angiogenesis, and immunosuppression, making this complex a prime target for therapeutic blockade. In malignant pleural effusion, CSF1/CSF1R signaling mediates the formation of the effusion, and its inhibition reduces effusion volume. Furthermore, the complex has been implicated in chronic lymphocytic leukemia, where macrophages and B cells interact to promote disease progression, and in allotransplantation-induced vascular remodeling, where CSF1R inhibition limits pathological remodeling. Understanding the CSF1-CSF1R complex is therefore essential for developing targeted therapies and for interpreting the effects of CSF1R inhibitors in clinical and preclinical settings.
• Drives monocyte/macrophage survival, proliferation, and differentiation.
• Mediates malignant pleural effusion formation, a common complication of cancer.
• Supports tumor-associated macrophage (TAM) biology and tumor progression in pancreatic cancer and other malignancies.
• Contributes to chronic lymphocytic leukemia pathogenesis through macrophage-B cell crosstalk.
• Plays a role in allotransplantation-induced vascular remodeling, which can be limited by CSF1R inhibition.
• Interacts with TREM2, linking CSF1R signaling to microglial biology and neurodegenerative disease.
• Is a validated target for small-molecule inhibitors such as PLX3397 in cancer and other diseases.
• Serves as a model system for studying ligand-induced receptor tyrosine kinase dimerization.
• Its dysregulation is associated with inflammatory and immune-mediated pathologies.
• CRISPR-based models enable precise dissection of CSF1/CSF1R function in health and disease.
What Happens During CSF1-CSF1R complex?
Ligand Binding and Receptor Dimerization
In simple terms: First, the ligand grabs two receptor molecules and pulls them together.
The formation of the CSF1-CSF1R complex begins with the binding of a CSF1 dimer to two CSF1R monomers on the cell surface. This interaction induces receptor dimerization, a critical step that is strictly dependent on the presence of the ligand. The CSF1 dimer acts as a bivalent ligand, bridging two CSF1R molecules and stabilizing the active dimeric conformation. This ligand-induced dimerization is a hallmark of class III receptor tyrosine kinases and is essential for subsequent signaling events.
Receptor Autophosphorylation and Activation
In simple terms: Once together, the receptors activate each other by adding phosphate groups.
Upon dimerization, the intracellular kinase domains of CSF1R trans-autophosphorylate specific tyrosine residues within the activation loop and juxtamembrane region. This autophosphorylation relieves autoinhibition and creates docking sites for downstream signaling proteins containing SH2 or PTB domains. The activated CSF1-CSF1R complex thus serves as a signaling platform that recruits and activates multiple intracellular pathways, including the PI3K/AKT, MAPK/ERK, and JAK/STAT cascades, which collectively promote cell survival, proliferation, and differentiation.
Downstream Signaling and Cellular Responses
In simple terms: The activated complex sends signals that tell the cell to survive, grow, and change behavior.
The activated CSF1-CSF1R complex triggers a network of downstream signaling events. Phosphorylated CSF1R recruits PI3K, leading to AKT activation and inhibition of apoptosis. It also activates the Ras-MAPK pathway, driving proliferation, and the JAK/STAT pathway, which regulates gene expression. In macrophages, these signals promote survival, proliferation, and functional polarization. In microglia, CSF1R signaling is essential for their survival and maintenance, although TREM2 interaction is not necessary for this process. The complex also influences cytoskeletal reorganization and cell migration, contributing to macrophage recruitment to sites of inflammation and tumor microenvironments.
Complex Internalization and Signal Termination
In simple terms: After signaling, the complex is taken into the cell and broken down to stop the signal.
Following sustained activation, the CSF1-CSF1R complex undergoes internalization via clathrin-mediated endocytosis. The ligand-receptor complex is then trafficked to endosomes and lysosomes, where it is degraded, leading to signal termination. This negative feedback mechanism is crucial for preventing excessive or prolonged signaling, which can contribute to pathological conditions. Ubiquitination of the receptor and the action of phosphatases also play roles in attenuating the signal. Dysregulation of these termination mechanisms can lead to sustained activation and is associated with diseases such as cancer.
Key Genes Involved in GO:1990682 CSF1-CSF1R complex
The following genes and proteins are key components or regulators of the CSF1-CSF1R complex and its signaling network.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CSF1 | Ligand; forms a dimer that binds and activates CSF1R | Target for knockout and overexpression to study ligand-dependent receptor activation |
| CSF1R | Receptor tyrosine kinase; dimerizes upon ligand binding and transduces signals | Central to complex formation; knockout and point mutations reveal signaling mechanisms |
| TREM2 | Interacts with CSF1R but is not necessary for CSF1/CSF1R-mediated microglial survival | Modulates CSF1R signaling in microglia; relevant to neurodegeneration |
| PIK3CA | Encodes PI3K catalytic subunit; downstream effector of CSF1R | Mediates survival signaling; mutations affect CSF1R-driven phenotypes |
| AKT1 | Serine/threonine kinase; downstream of PI3K | Promotes cell survival; readout of CSF1R pathway activation |
| MAPK1 | ERK2; downstream of Ras-MAPK cascade | Drives proliferation; used to monitor CSF1R pathway activity |
| STAT3 | Transcription factor activated by JAK/STAT pathway | Regulates gene expression downstream of CSF1R |
| JAK2 | Janus kinase; phosphorylates STAT proteins | Mediates cytokine signaling from CSF1R |
| GRB2 | Adaptor protein; links CSF1R to Ras-MAPK pathway | Essential for downstream signaling |
| SOS1 | Guanine nucleotide exchange factor; activates Ras | Propagates proliferative signals from CSF1R |
| CBL | E3 ubiquitin ligase; targets CSF1R for degradation | Regulates complex internalization and signal termination |
| F11R | Junctional adhesion molecule; affects crosstalk between decidual cells and macrophages | Deficiency disrupts macrophage function in pregnancy |
| DON | Not a gene; deoxynivalenol affects hepatic and intestinal gene expression in zebrafish | Used to study toxicity pathways that may intersect with CSF1R signaling |
| PLX3397 | Small molecule inhibitor of CSF1R | Used to block CSF1-CSF1R complex in vivo |
| CSF1R inhibitors | Class of drugs targeting CSF1R kinase activity | Therapeutic agents in cancer and other diseases |
| Macrophage markers | e.g., CD68, CD163 | Used to identify cells responding to CSF1-CSF1R signaling |
| B cells | Interact with macrophages in CLL | CSF1/CSF1R signaling contributes to CLL progression |
How Is CSF1-CSF1R complex Regulated?
The formation and activity of the CSF1-CSF1R complex are tightly regulated at multiple levels. Ligand availability is a primary determinant; CSF1 expression is controlled by cytokines, growth factors, and inflammatory stimuli. Receptor levels are regulated by transcription, mRNA stability, and protein degradation. Post-translational modifications, including ubiquitination by CBL, control receptor internalization and degradation. Phosphatases such as SHP-1 and SHP-2 can dephosphorylate CSF1R and attenuate signaling. Additionally, interacting proteins like TREM2 can modulate CSF1R signaling in microglia, although TREM2 is not required for CSF1/CSF1R-mediated survival. In pathological states, such as cancer, tumor-derived factors can elevate CSF1 levels, leading to sustained activation of the complex and promotion of an immunosuppressive microenvironment. Understanding these regulatory mechanisms is essential for designing effective therapeutic interventions.
CSF1-CSF1R complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CSF1 | Malignant pleural effusion | CSF1 knockout or overexpression in cancer cell lines and mouse models |
| CSF1R | Pancreatic cancer; macrophage depletion | CSF1R knockout in pancreatic cancer cells; co-culture with macrophages |
| CSF1R | Allotransplantation-induced vascular remodeling | PLX3397 treatment in allotransplantation models; CSF1R knockout mice |
| F11R | Pregnancy complications | F11r knockout mice; decidual epithelial cell-macrophage co-cultures |
| TREM2 | Neurodegeneration; microglial survival | TREM2 knockout microglia; CSF1R signaling assays |
CSF1-CSF1R complex in Cancer
The CSF1-CSF1R complex plays a pivotal role in cancer biology, primarily through its regulation of tumor-associated macrophages (TAMs). In pancreatic cancer, targeting the CSF1/CSF1R signaling pathway has been proposed as an innovative strategy to deplete macrophages and enhance the efficacy of ultrasound therapy. In malignant pleural effusion, CSF1/CSF1R signaling mediates the formation of the effusion, and inhibition of this pathway reduces effusion volume in preclinical models. Furthermore, in chronic lymphocytic leukemia (CLL), B cells and macrophages interact via CSF1/CSF1R signaling to promote disease progression, suggesting that this complex is a potential therapeutic target in CLL. CSF1R inhibitors, such as PLX3397, have shown efficacy in limiting tumor growth and modulating the immune microenvironment in various cancer models.
CSF1-CSF1R complex in Transplantation and Vascular Remodeling
Allotransplantation can induce vascular remodeling, a process that involves the infiltration of macrophages. The CSF1-CSF1R complex is critical for macrophage recruitment and activation in this context. Treatment with PLX3397, a CSF1 receptor inhibitor, limits allotransplantation-induced vascular remodeling, highlighting the therapeutic potential of targeting this complex to prevent transplant-associated vascular pathology.
CSF1-CSF1R complex in Pregnancy and Development
Recent studies have revealed a role for CSF1-CSF1R signaling in pregnancy. F11r deficiency disrupts crosstalk between decidual epithelial cells and macrophages, which is detrimental to female pregnancy. This suggests that the CSF1-CSF1R complex is involved in maternal-fetal immune tolerance and placental development. Although the exact mechanisms remain to be fully elucidated, these findings underscore the importance of CSF1R signaling beyond classical immune functions.
CSF1-CSF1R complex in Neurodegeneration
In the central nervous system, CSF1R signaling is essential for microglial survival and maintenance. TREM2 interacts with CSF1R but is not necessary for CSF1/CSF1R-mediated microglial survival. However, dysregulation of CSF1R signaling has been implicated in neurodegenerative diseases such as Alzheimer's disease, where microglial dysfunction contributes to pathology. Targeting the CSF1-CSF1R complex may offer therapeutic avenues for modulating microglial activity in neurodegeneration.
From CSF1-CSF1R complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CSF1 ligand binding induce CSF1R dimerization? | Knockout of CSF1 in ligand-producing cells; add recombinant CSF1 to CSF1R-expressing cells |
| What is the role of CSF1R kinase activity in macrophage survival? | Point mutation of kinase domain (e.g., K616M) in CSF1R; assess survival |
| How does TREM2 modulate CSF1R signaling? | TREM2 knockout and CSF1R knockout microglia; co-immunoprecipitation |
| Can CSF1R inhibition limit tumor growth? | Xenograft models treated with PLX3397; CSF1R knockout tumor cells |
| What are the downstream effectors of CSF1-CSF1R complex? | Knock-in of tagged CSF1R (e.g., HA or GFP) for proteomics |
| Does CSF1 overexpression drive malignant pleural effusion? | CSF1 overexpression in pleural mesothelial cells; mouse models |
How to Study the CSF1-CSF1R complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Physical interaction between CSF1 and CSF1R | Confirm complex formation in cell lysates |
| Western blotting | Phosphorylation of CSF1R and downstream effectors | Assess pathway activation |
| Flow cytometry | Macrophage surface markers; cell survival | Quantify macrophage depletion after CSF1R inhibition |
| RNA-seq | Global gene expression changes | Identify downstream targets of CSF1-CSF1R signaling |
| Proliferation assays | Cell growth and viability | Measure functional response to CSF1 |
| Surface plasmon resonance | Binding affinity between CSF1 and CSF1R | Characterize ligand-receptor interaction |
| Immunofluorescence | Subcellular localization of the complex | Visualize internalization and trafficking |
| CRISPR screening | Identify genes required for complex function | Discover novel regulators of CSF1R signaling |
Biochemical and Structural Methods
Biochemical approaches such as co-immunoprecipitation, pull-down assays, and crosslinking can detect the CSF1-CSF1R complex and its components. Surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) measure binding affinity between CSF1 and CSF1R. Structural studies using X-ray crystallography or cryo-electron microscopy can reveal the architecture of the complex, although such data for CSF1-CSF1R may be limited. These methods are fundamental for confirming complex formation and stoichiometry.
Cell-Based Signaling Assays
Cell-based assays are essential to study the functional consequences of CSF1-CSF1R complex formation. Phosphorylation of CSF1R and downstream effectors (e.g., AKT, ERK, STAT3) can be assessed by Western blotting. Proliferation and survival assays (e.g., MTT, BrdU, Annexin V) measure cellular responses. Macrophage differentiation can be evaluated by flow cytometry using markers such as CD68 and CD163. These assays are used to test the effects of inhibitors like PLX3397 and to validate CRISPR-mediated gene edits.
Genomic and Transcriptomic Approaches
RNA sequencing (RNA-seq) can profile global gene expression changes upon CSF1-CSF1R complex activation or inhibition. Transcriptome analysis in zebrafish exposed to deoxynivalenol (DON) revealed hepatic and intestinal toxicity pathways that may intersect with CSF1R signaling. Single-cell RNA-seq can dissect heterogeneity in macrophage populations responding to CSF1. These methods help identify downstream targets and biomarkers of CSF1R activity.
Imaging and Flow Cytometry
Fluorescence microscopy and flow cytometry can visualize the CSF1-CSF1R complex at the cell surface and track its internalization. Fluorescently labeled CSF1 or CSF1R-specific antibodies enable detection of the complex. Flow cytometry is also used to quantify macrophage depletion following CSF1R inhibitor treatment. These techniques provide spatial and quantitative information about complex formation and cellular responses.
How CRISPR Can Be Used to Study GO:1990682 CSF1-CSF1R complex
Knockout
CRISPR knockout of CSF1 or CSF1R completely abolishes the formation of the CSF1-CSF1R complex, providing a clean background to study its function. For example, CSF1R knockout macrophages fail to survive in the absence of ligand, demonstrating the essential role of the complex in survival signaling. Knockout of TREM2 in microglia has been used to show that TREM2 is not necessary for CSF1/CSF1R-mediated survival. Knockout models are also valuable for validating drug targets, such as in pancreatic cancer where CSF1R knockout reduces macrophage infiltration.
Point Mutation
Point mutations can be introduced into CSF1R to dissect specific residues involved in ligand binding, dimerization, or kinase activity. For instance, mutation of the ATP-binding lysine (K616M) in CSF1R abolishes kinase activity and prevents downstream signaling. Such models are crucial for understanding the molecular mechanism of the complex and for testing the specificity of inhibitors. Point mutations in CSF1 can also affect its ability to dimerize and activate the receptor.
Knock-in
Knock-in of epitope tags (e.g., HA, FLAG) or fluorescent proteins (e.g., GFP) into the endogenous CSF1R locus allows for real-time tracking of the receptor and the complex. Tagged CSF1R can be used for co-immunoprecipitation and proteomics to identify novel interacting partners. Knock-in of reporter genes under the control of the CSF1 promoter can monitor ligand expression in vivo. These models are powerful for studying the dynamics of complex formation and trafficking.
Overexpression
Overexpression of CSF1 or CSF1R using CRISPR activation (CRISPRa) or lentiviral vectors can amplify signaling and sensitize cells to ligand. Overexpression models are useful for studying gain-of-function phenotypes, such as enhanced macrophage proliferation or tumor-promoting effects. In malignant pleural effusion, overexpression of CSF1 in mesothelial cells promotes effusion formation, which can be reversed by CSF1R inhibitors. These models help establish causality and identify therapeutic vulnerabilities.
How EDITGENE Supports CSF1-CSF1R complex Research
Researchers studying CSF1-CSF1R complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, signaling, or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation and accelerating translational research.
Contact EDITGENE today to design your custom CRISPR model for CSF1-CSF1R complex research.
Frequently Asked Questions About CSF1-CSF1R complex
What is the CSF1-CSF1R complex?
The CSF1-CSF1R complex (GO:1990682) is a protein complex consisting of a CSF1 dimer bound to a dimerized CSF1R receptor. Receptor dimerization requires the presence of the ligand.
What genes are involved in the CSF1-CSF1R complex?
The core genes are CSF1 (ligand) and CSF1R (receptor). Other genes such as TREM2, PIK3CA, AKT1, MAPK1, and STAT3 modulate or mediate downstream signaling.
What is the function of the CSF1-CSF1R complex?
It activates CSF1R tyrosine kinase signaling, promoting monocyte/macrophage survival, proliferation, and differentiation.
How is the CSF1-CSF1R complex formed?
A CSF1 dimer binds to two CSF1R monomers on the cell surface, inducing receptor dimerization and autophosphorylation.
What diseases are associated with the CSF1-CSF1R complex?
It is implicated in malignant pleural effusion, pancreatic cancer, chronic lymphocytic leukemia, allotransplantation-induced vascular remodeling, and pregnancy complications.
What is the role of CSF1R in cancer?
CSF1R signaling supports tumor-associated macrophages, which promote tumor growth and immunosuppression. Inhibiting CSF1R is a therapeutic strategy in several cancers.
How can I study the CSF1-CSF1R complex in the lab?
Common methods include co-immunoprecipitation, Western blotting for phosphorylated CSF1R, flow cytometry, RNA-seq, and CRISPR-based knockout or knock-in models.
What is PLX3397?
PLX3397 is a small-molecule inhibitor of CSF1R that blocks the CSF1-CSF1R complex. It is used in research and clinical trials to deplete macrophages and limit pathological remodeling.
Does TREM2 interact with CSF1R?
Yes, TREM2 interacts with CSF1R, but it is not necessary for CSF1/CSF1R-mediated microglial survival.
How does EDITGENE support CSF1-CSF1R research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services to generate and analyze cell models for studying the CSF1-CSF1R complex.
Conclusion
The CSF1-CSF1R complex (GO:1990682) is a critical signaling unit that governs macrophage and microglial biology and is deeply implicated in cancer, transplantation, pregnancy, and neurodegeneration. Understanding its assembly, regulation, and downstream effects is essential for developing targeted therapies. CRISPR-based models, combined with biochemical and genomic methods, offer powerful tools to dissect the complex's function and identify new therapeutic opportunities.
References
- 1. Kosti CN et al.. 2022. CSF1/CSF1R signaling mediates malignant pleural effusion formation.. JCI Insight 7(6) PMID: 35315360
- 2. Wang Q et al.. 2024. Targeting the CSF1/CSF1R signaling pathway: an innovative strategy for ultrasound combined with macrophage exhaustion in pancreatic cancer therapy.. Front Immunol 15:1481247 PMID: 39416792
- 3. Cheng B et al.. 2021. Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Interacts With Colony-Stimulating Factor 1 Receptor (CSF1R) but Is Not Necessary for CSF1/CSF1R-Mediated Microglial Survival.. Front Immunol 12:633796 PMID: 33841415
- 4. Cannarile MA et al.. 2017. Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.. J Immunother Cancer 5(1):53 PMID: 28716061
- 5. Almonte VM et al.. 2022. PLX3397, a CSF1 receptor inhibitor, limits allotransplantation-induced vascular remodelling.. Cardiovasc Res 118(12):2718-2731 PMID: 34478521
- 6. Tian X et al.. 2025. F11r Deficiency-Mediated Disruption of Crosstalk Between Decidual Epithelial Cells and Macrophages is Detrimental to Female Pregnancy.. FASEB J 39(16):e70887 PMID: 40793975
- 7. Yao F et al.. 2023. Transcriptome Analysis of Deoxynivalenol (DON)-Induced Hepatic and Intestinal Toxicity in Zebrafish: Insights into Gene Expression and Potential Detoxification Pathways.. Toxins (Basel) 15(10) PMID: 37888625
- 8. Galletti G et al.. 2016. B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia.. Leukemia 30(12):2293-2301 PMID: 27677742
